VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

Bullboard Posts

Comment by hassyon Apr 13, 2018 10:41pm

269 Views

Post# 27883985

RE:reading george's letter again

Spoke to George- FDA raised questions over the past weeks (months?), which is not unexpected, but VPT team has responded fully. Given how the new team prepared and got CE in such a short order, I have great confidence that the responses provided should not be an issue.

IMHO, unless FDA somehow comes up with more question(s), we should have a positive outcome over the next 10 days. When I called the company back in Feb, they were expecting 60-90 days approval time frame..I would give the story a few more weeks to see how this unfolds.

Bullboard Posts

This junior mining stock offers billions in market exposure